Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain – results of a double-blind placebo-controlled trial (MONTAS)
- 1 June 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pain
- Vol. 97 (3) , 223-233
- https://doi.org/10.1016/s0304-3959(02)00020-9
Abstract
Efficacy, long-term effectiveness and safety of opioids in chronic non-tumor associated pain syndromes (NTAS) are still under debate. The study (MONTAS) was performed by physicians and psychologists as a multicenter prospective, randomized, double-blind placebo-controlled crossover trial, foKeywords
This publication has 35 references indexed in Scilit:
- 2b Opioids in chronic painBaillière's Clinical Anaesthesiology, 1998
- Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic painThe Lancet, 1997
- Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trialPain, 1995
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995
- Behinderungseinschätzung bei chronischen SchmerzpatientenDer Schmerz, 1994
- Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanismsNeurology, 1994
- Chronic Nonmalignant Pain Treated with Long-Term Oral Narcotic AnalgesicsAnnals of Clinical Psychiatry, 1992
- Überweisungsgrund: “therapieresistente” TumorschmerzenDer Schmerz, 1990
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988
- Opiates in the Management of Chronic PainClinics in Anaesthesiology, 1983